These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27748335)

  • 1. Autoimmune Hepatitis-related Cirrhosis: Clinical Features and Effectiveness of Immunosuppressive Treatment in Chinese Patients.
    Li YN; Ma H; Zhou L; Zhang J; Guo LP; Li SQ; Qian YQ; Wang BM
    Chin Med J (Engl); 2016 Oct; 129(20):2434-2440. PubMed ID: 27748335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
    Cao LL; Zhang M; Zhu SS; Dong Y; Xu ZQ; Chen DW; Wang LM; Wang FC; Gan Y; Yan JG; Wang P; Li AQ
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):40-45. PubMed ID: 30630230
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1.
    Hino-Arinaga T; Ide T; Kuromatsu R; Miyajima I; Ogata K; Kuwahara R; Hisamochi A; Torimura T; Sata M;
    J Gastroenterol; 2012 May; 47(5):569-76. PubMed ID: 22187167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis.
    Zachou K; Gatselis NK; Arvaniti P; Gabeta S; Rigopoulou EI; Koukoulis GK; Dalekos GN
    Aliment Pharmacol Ther; 2016 May; 43(10):1035-47. PubMed ID: 26991238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study.
    Kim BH; Kim YJ; Jeong SH; Tak WY; Ahn SH; Lee YJ; Jung EU; Lee JI; Yeon JE; Hwang JS; Um SH; Seo YS; Kim YS; Song BC; Kim JH; Jung YK; Park CK; Kim KA; Min HJ; Cho EY; Lee ES; Kwon SY; Chae HB; Kim DJ; Shin SR
    J Gastroenterol Hepatol; 2013 Jan; 28(1):128-34. PubMed ID: 23033899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stopping immunosuppressive treatment in autoimmune hepatitis (AIH): Is it justified (and in whom and when)?
    Harrison L; Gleeson D
    Liver Int; 2019 Apr; 39(4):610-620. PubMed ID: 30667576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.
    Feld JJ; Dinh H; Arenovich T; Marcus VA; Wanless IR; Heathcote EJ
    Hepatology; 2005 Jul; 42(1):53-62. PubMed ID: 15954109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.
    Dhaliwal HK; Hoeroldt BS; Dube AK; McFarlane E; Underwood JC; Karajeh MA; Gleeson D
    Am J Gastroenterol; 2015 Jul; 110(7):993-9. PubMed ID: 26010310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis.
    Mohamadnejad M; Malekzadeh R; Nasseri-Moghaddam S; Hagh-Azali S; Rakhshani N; Tavangar SM; Sedaghat M; Alimohamadi SM
    Dig Dis Sci; 2005 Mar; 50(3):547-51. PubMed ID: 15810640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New predictive factors of poor response to therapy in autoimmune hepatitis: role of mean platelet volume.
    Abdel-Razik A; Mousa N; Zakaria S; Elhelaly R; Elzehery R; Zalata K; Awad M; Eldeeb AA; Abdelsalam M
    Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1373-1379. PubMed ID: 29035910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune hepatitis: Single-center experience of clinical presentation, response to treatment and prognosis in Saudi Arabia.
    Fallatah HI; Akbar HO; Qari YA
    Saudi J Gastroenterol; 2010; 16(2):95-9. PubMed ID: 20339178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors of poor response to therapy in Autoimmune Hepatitis.
    Muratori P; Lalanne C; Bianchi G; Lenzi M; Muratori L
    Dig Liver Dis; 2016 Sep; 48(9):1078-81. PubMed ID: 27378707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histological regression of liver fibrosis with immunosuppressive therapy in autoimmune hepatitis].
    Valera JM; Smok G; Márquez S; Poniachik J; Brahm J
    Gastroenterol Hepatol; 2011 Jan; 34(1):10-5. PubMed ID: 21194803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune hepatitis in children in Eastern Denmark.
    Vitfell-Pedersen J; Jørgensen MH; Müller K; Heilmann C
    J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):376-9. PubMed ID: 22644464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis.
    Ozaslan E; Efe C; Heurgué-Berlot A; Kav T; Masi C; Purnak T; Muratori L; Ustündag Y; Bresson-Hadni S; Thiéfin G; Schiano TD; Wahlin S; Muratori P
    Clin Gastroenterol Hepatol; 2014 May; 12(5):863-9. PubMed ID: 24076417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis.
    Miyake Y; Iwasaki Y; Terada R; Takagi S; Okamaoto R; Ikeda H; Sakai N; Makino Y; Kobashi H; Takaguchi K; Sakaguchi K; Shiratori Y
    J Hepatol; 2005 Dec; 43(6):951-7. PubMed ID: 16143423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicolaboratory characteristics of Japanese patients with primary biliary cirrhosis-autoimmune hepatitis overlap.
    Saito H; Rai T; Takahashi A; Kanno Y; Monoe K; Irisawa A; Ohira H
    Fukushima J Med Sci; 2006 Dec; 52(2):71-7. PubMed ID: 17427758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes.
    Yokokawa J; Saito H; Kanno Y; Honma F; Monoe K; Sakamoto N; Abe K; Takahashi A; Yokokawa H; Ohira H
    J Gastroenterol Hepatol; 2010 Feb; 25(2):376-82. PubMed ID: 19817953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of age in presentation, response to therapy and outcome of autoimmune hepatitis.
    Baven-Pronk MAMC; Biewenga M; van Silfhout JJ; van den Berg AP; van Buuren HR; Verwer BJ; van Nieuwkerk CMJ; Bouma G; van Hoek B
    Clin Transl Gastroenterol; 2018 Jul; 9(6):165. PubMed ID: 29961755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and Outcomes of Autoimmune Hepatitis from a Tertiary Paediatric Centre, Cape Town, South Africa.
    Yassin S; De Lacy R; Pillay K; Goddard E
    J Trop Pediatr; 2020 Aug; 66(4):448-457. PubMed ID: 31943108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.